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Abstract
In recent years a number of the genes that regulate muscle formation and maintenance in higher organisms have been
identified. Studies employing invertebrate and vertebrate model organisms have revealed that many of the genes required
for early mesoderm specification are highly conserved throughout evolution. Less is known about the molecules that
mediate the steps subsequent to myogenesis, e. g. myotube guidance and attachment to tendon cells. We use the
stereotypic pattern of the Drosophila embryonic body wall musculature in genetic approaches to identify novel factors
required for muscle attachment site selection. Here, we show that Wnt5 is needed in this process. The lateral transverse
muscles frequently overshoot their target attachment sites and stably attach at novel epidermal sites in Wnt5 mutant
embryos. Restoration of WNT5 expression in either the muscle or the tendon cell rescues the mutant phenotype.
Surprisingly, the novel attachment sites in Wnt5 mutants frequently do not express the Stripe (SR) protein which has been
shown to be required for terminal tendon cell differentiation. A muscle bypass phenotype was previously reported for
embryos lacking the WNT5 receptor Derailed (DRL). drl and Wnt5 mutant embryos also exhibit axon path finding errors. DRL
belongs to the conserved Ryk receptor tyrosine kinase family which includes two other Drosophila orthologs, the Doughnut
on 2 (DNT) and Derailed-2 (DRL-2) proteins. We generated a mutant allele of dnt and find that dnt, but not Drl-2, mutant
embryos also show a muscle bypass phenotype. Genetic interaction experiments indicate that drl and dnt act together,
likely as WNT5 receptors, to control muscle attachment site selection. These results extend previous findings that at least
some of the molecular pathways that guide axons towards their targets are also employed for guidance of muscle fibers to
their appropriate attachment sites.
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Introduction
The establishment of the musculature in higher organisms is a
multistep process involving myoblast specification and fusion,
followed by guidance of the myotubes towards the muscle
attachment sites (MAS) (reviewed in [1]). Final differentiation of
both the muscle and the attachment sites is initiated when the
multinucleated fiber attaches to the tendon cell. Intercellular
communication between the myofiber and the tendon cells
mediated by secreted or transmembrane proteins is essential to
ensure a stable muscle attachment resistant to contraction-induced
detachment (reviewed in [2]). Only a few molecules that regulate
these different stages of muscle pattern formation have been
identified so far, but most characterized factors show a remarkable
degree of functional conservation between vertebrates and
invertebrates. The Drosophila embryonic body wall musculature
with its stereotyped pattern and amenability to genetic analysis has
been an excellent model to unravel the cellular and molecular
mechanisms underlying this process [2,3,4,5,6,7].
The Drosophila somatic musculature is established into a
stereotypical segmentally reiterated pattern during embryonic
development. Pattern formation starts at 7.5 hours after egg laying
(AEL) and is completed 5.5 hours later when the muscle fibers
form stable contacts with the epidermal tendon cells in the insects’
exoskeleton (reviewed in [6]). Muscles persist through the larval
stages until the pupal stage when they degenerate and are replaced
by the adult musculature [8]. Initially, each embryonic somatic
muscle fiber is formed by the fusion of a muscle founder cell and a
number of fusion-competent myoblasts [9]. The fusion process
creates multinucleated myofibers whose two leading edges
subsequently migrate towards clusters of tendon cell progenitors
in the epidermis [1,2,7].
The initial determination of the tendon cell progenitors in
Drosophila is provided by segment polarity genes such as wingless
(wg) and hedgehog that activate the early growth response (Egr)-like
transcription factor Stripe (SR) in segmentally-reiterated clusters of
epidermal cells [10]. Once SR is activated these cells become
tendon cell progenitors and SR expression is both necessary and
sufficient to promote muscle migration towards these cells
[11,12,13]. However, final differentiation of the single selected
tendon cell requires direct interaction with a muscle fiber
(reviewed in [2]).
Upon muscle attachment, Vein, a neuregulin-like ligand
secreted from muscle, accumulates at the muscle-tendon junction
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tendon cell progenitor that is contacted by the muscle fiber [14].
This signal maintains SR expression and results in the differen-
tiation of the progenitor into a mature tendon cell. The precursor
cells that are not contacted by a muscle fiber cease to express SR
and do not differentiate into tendon cells. SR, in turn, induces the
expression of both the Slit [15] and Leucine-rich tendon-specific
proteins [16]. These proteins then act as positive and negative
guidance cues, respectively, for the muscle fibers. The final stage of
tendon cell determination is defined by the association of aPS2/
bPS Integrin (at the muscle tip) with Thrombospondin (TSP; at
the extracellular matrix of the tendon cell) mediating the
formation of a myotendinous junction at the attachment site
[17,18]. This junction withstands the mechanical forces that occur
during larval locomotion.
Several proteins expressed in the muscle or tendon cells have
been shown to control muscle guidance and attachment. The
Roundabout (ROBO) protein which is expressed in a subset of
muscle fibers, acts as the guidance receptor for Slit produced by
the tendon cells [15]. ROBO and Slit interactions are also needed
for guidance of axons across the Drosophila embryonic ventral
midline in the central nervous system (CNS) [19,20]. The Kontiki
(KON) protein is expressed on the tips of a subset of growing
myotubes and is needed, in a pathway involving the Glutamate
receptor binding protein protein, for their guidance to the correct
attachment site [21]. The tendon cell-derived ligand of KON
remains to be identified.
Another molecule shown to act as a guidance receptor both for
axons and myotubes is DRL (reviewed in [22]). It was initially
identified in screens for genes required for axon pathfinding in the
Drosophila embryo [23,24] and for learning and memory in the
adult [25]. It was also shown to be required for the correct tendon
cell attachment of a subset of the lateral transverse muscles (LTMs
21–23) [24].
DRL is a member of the conserved transmembrane receptor
tyrosine kinase Ryk family [26,27] which bears an extracellular
Wnt-binding WIF domain and an intracellular tyrosine kinase
homologous domain. C. elegans, zebra fish and mammals have a
single Ryk ortholog while three Ryk proteins, DRL, DRL-2 and
DNT, are encoded in the fruit fly genome. DRL-2 and DNT share
35% and 60% amino acid identity, respectively, with DRL.
The Drosophila Wnt family member WNT5 acts as a ligand for
DRL in the nervous system and both genes are required for the
proper axon guidance leading to correct formation of the
embryonic ventral cord commissures [28,29]. Wnt proteins are
highly conserved secreted molecules that play roles in diverse
signaling pathways acting during normal development and are
perturbed during oncogenesis [30]. Wnt genes are also important
for the development and function of the nervous system
throughout the animal kingdom. They have roles in neuronal
differentiation, axon extension, axon guidance and neural circuit
assembly in both vertebrates and invertebrates (reviewed in
[31,32]).
A number of at least partially distinct Wnt signaling pathways
have been uncovered and, of these, the canonical Wnt pathway is
most extensively studied (reviewed in [33]). Wnt binding to the
Frizzled and LRP co-receptors results in the accumulation of b-
catenin in the cytosol and its translocation to the nucleus where it
activates TCF/LEF-dependent transcription of target genes.
There are also alternative, non-canonical, Wnt pathways, e. g.,
the Ca
2+, Planar Cell Polarity (PCP) and Ryk pathways (reviewed
in [22,30,34,35]). The least is known about the downstream
signaling components of the Wnt pathway that acts via the RYK
receptor.
Wnt/Ryk interactions are essential both in Drosophila and
mammals for normal nervous system development (reviewed in
[22,31]). Ryks have been characterized as ‘‘dead’’-tyrosine kinases
based on the observation that they contain amino acid
substitutions on sites in the potential kinase domain that would
likely render them inactive as protein kinases [26,27]. However, it
is still unclear whether Ryk’s kinase domain might be active under
certain conditions [36]. During mammalian brain neurogenesis,
Ryk has been reported to be cleaved at a conserved sequence in
the transmembrane domain resulting in the translocation of the
cytoplasmic domain to the nucleus where it may regulate
transcription [37]. WNT5/DRL signaling during formation of
the Drosophila embryonic nervous system requires the Src family
non-receptor tyrosine kinase, SRC64B [38], indicating that it may
be involved in actively transducing an intracellular signal upon
WNT5 binding to DRL.
Here, we present evidence that Wnt5 is required for appropriate
attachment of a subset of embryonic muscles, the LTMs 21, 22
and 23. In animals lacking WNT5, myotubes overshoot their
normal attachment sites and form ectopic contacts. This bypass
phenotype was previously observed in drl mutant embryos that
lack DRL which is normally expressed in the LTMs [39,40]. DRL
was found to be required in the muscle fiber to rescue the guidance
defect [39]. We find that WNT5, a secreted protein, expressed in
either the tendon cells or the muscle fiber is sufficient to restore
correct muscle attachment in Wnt5 mutant embryos. The majority
of the novel ectopic attachment sites in drl and Wnt5 mutants do
not express SR, indicating that it is not needed to form or maintain
these novel muscle attachments to the body wall. The ectopic
attachment sites persist through larval stages and accumulate
Fasciculin2 (FAS2), a cell adhesion protein that is normally present
in both the muscle and the tendon cells at the myotendinous
junction. Finally, we generated a mutant allele of dnt, and found
that it is also required for correct LTM attachment, while the third
Drosophila Ryk family member, Drl-2, is not.
Results
The embryonic muscles 21 through 23 often overshoot
their attachment sites when WNT5 is absent
The somatic mesoderm gives rise to a stereotypic segmentally-
reiterated set of body wall muscles during Drosophila embryonic
development. The muscle pattern of the abdominal hemisegments
A2 to A6 consists of 30 fibers that attach at both sides to tendon
cells in the epidermis [6]. The DRL receptor is required for the
correct attachment site selection by a subset of these muscles, the
LTMs (muscles 21–23 [39]). In wild type embryos, the LTMs
extend ventrally towards the dorsal border of muscle fiber 12 at
which site they attach to a tendon cell in the epidermis (Figs. 1A
and 1G). However, in the drl mutant, the LTMs frequently
overshoot their target and extend further ventrally passed muscle
13 or 6 to muscle fiber 7 and attach to an ectopic epidermal
attachment site ([39]; Figs. 1C and 1G). Usually, only one of the
three muscles per hemisegment exhibits this phenotype.
DRL also serves as an axon guidance receptor for the WNT5
protein during embryonic ventral nerve cord commissure
formation [29]. We wondered whether Wnt5 possibly also acts
during formation of the embryonic musculature. We therefore
examined the morphology of the embryonic muscle pattern in
Wnt5 mutants using an antibody against the Muscle Myosin
protein which labels all somatic muscles (Materials and Methods).
Most muscles develop normally and attach at their correct position
to the body wall in Wnt5
400 null mutant embryos. However, one or
more of the muscle fibers 21, 22 and 23 extends far more ventrally
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border of muscle 13 in 17% of the hemisegments scored (Fig. 1B
and Table 1). Occasionally, either muscle 6 or muscle 7 is absent
or not correctly attached in these mutants, but we did not observe
a correlation between the absence of muscles 6 or 7 and the bypass
phenotypes of the LTMs. In the drl mutant, this bypass phenotype
is more penetrant and is observed in 36% of the hemisegments,
while this phenotype was never observed in wild type control
embryos (Fig. 1C and Table 1; [39]). Since, the degree of
myotube overextension varies somewhat; we scored a fiber as
overshooting its target only when it extended ventrally and
attached ectopically beyond muscle 13 at the end of embryogen-
esis (stage 17, 18 hours AEL).
The number of LTMs that bypass their normal attachment sites
when drl alone or when drl and Wnt5 are both absent are the same
(Table 1), suggesting that drl and Wnt5 are in one pathway
controlling attachment site selection of the LTMs. However, the
significant difference in the numbers of overextended LTMs in
Wnt5 mutants (17%) versus that of drl mutants (36%) indicates that
DRL may bind multiple ligands to mediate muscle guidance. We
therefore investigated whether two other Drosophila Wnt family
members, Wnt4 and Wnt2, which are expressed in the epidermis or
the mesoderm and for which mutant alleles exist, exhibit bypass
phenotypes. In the Wnt2, Wnt4 double mutant no overshooting
occurs (Table 1) indicating that these Wnt proteins are unlikely to
be involved in LTM guidance and attachment.
Generation of a dnt mutant and establishing its role in
LTM attachment site selection
In Drosophila, there are two other Ryk proteins in addition to
DRL, DRL-2 and DNT (reviewed in [22]). Since drl mutants were
previously reported to display a partially penetrant muscle bypass
phenotype [39], we investigated whether the other two Ryk family
members are also required for attachment site selection. Drl-2
mutants exhibit defects in axon guidance in the antennal lobe [41]
and synaptic target specificity at the neuromuscular junction [42]
and characterized dnt mutant alleles have not been reported. We
did not observe any bypass phenotypes in the muscle pattern of
Drl-2
E124 mutants (Fig. 1D; Table 1). Furthermore, the numbers
of LTMs bypassing their normal attachment site does not increase
beyond those observed in the drl mutant in the drl, Drl-2 double
mutant (Table 1).
Figure 1. LTM muscle fibers 21, 22 and 23 frequently overshoot their attachment sites in Wnt5, drl and dnt mutant embryos. Stage 16
embryo body wall muscle preparations stained with anti-Muscle Myosin are shown for the wild type control (w
1118)( A), Wnt5
400 (B), drl
Red2 (C), Drl-
2
E124 (D), dnt
42.3 (E) and Df(2L)Exel6043 (F). Two hemisegments are displayed for each genotype with one set of muscles 21–23 labelled. In Wnt5, drl
and dnt mutants, LTMs frequently bypass their normal attachment at the epidermis at muscle 12 and instead extend ventrally beyond muscle 13 and
attach at a novel epidermal site located close to muscle fiber 7. Df(2L)Exel6043 mutant embryos, that lack both DNT and DRL, display this phenotype
in all hemisegments of the homozygous animals. The penetrance of these phenotypes is shown in Table 1. The muscle bypass phenotype is
schematically shown in panel (G). The * indicates the location of the novel, ectopic epidermal attachment in panels (B), (C), (E), (F) and (G). Anterior is
up and ventral is left.
doi:10.1371/journal.pone.0032297.g001
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element, P{EP}dnt
EP2158, inserted 350 base pairs upstream of the
dnt ATG translational initiator codon to generate mutants in this
gene (Materials and Methods). A mutant allele of dnt, dnt
42.3, was
obtained by imprecise excision of the P-element resulting in a
deletion of 2322 base pairs uncovering most of the first exon of the
dnt transcript. This deletion removes the ATG initiator codon, the
first 15 amino acids of the Wnt-binding WIF domain and the 39
splice donor site (Fig. 2A). RNA in situ analyses of the dnt
42.3 line
indicates that the mutant embryos have no detectable dnt
transcript (compare Figs. 2B and 2C). Mutants are viable as
homozygotes and analysis of their embryonic musculature
indicates that a LTM bypass phenotype is observed in 8% of the
hemisegments in the absence of dnt (Table 1), while the rest of the
muscle pattern appears normal.
WNT5 likely acts through DRL and DNT to mediate
muscle attachment site selection
The proximity of the drl and dnt genes to each other precluded
us from recombining a drl allele with dnt
42.3 to make a mutant line
lacking both proteins. Therefore, in order to investigate whether
drl and dnt function redundantly in LTM attachment site selection,
we employed two independently generated deficiency chromo-
somes that uncover both genes. Deficiency Df(2L)ED1231 has
breakpoints at 37C5 and 37E3 while the smaller deficiency
Df(2L)Exel6043 at 37C5 and 37D7 (http://flybase.org/). Trans-
heterozygotes bearing one copy of either deficiency and one copy
of the drl mutation show an increase in penetrance of the bypass
phenotype to 50% (as compared to 36% in the drl homozygous
mutant), while dnt
42.3/Df(2)Exel6043 embryos have a phenotypic
penetrance of 8% (Table 1). Virtually all hemisegments display
one or more bypassing LTMs (96%) in embryos homozygous for
either deficiency (Fig. 1F, Table 1). These results indicate that drl
and dnt likely act together to mediate appropriate attachment of
the LTMs.
We generated animals bearing the Df(2L)Exel6043 deficiency in
the Wnt5 mutant background to determine whether Wnt5 interacts
with drl and dnt. Neither Wnt5 nor the deficiency heterozygotes
display the muscle bypass phenotype, however females which are
heterozygous for Wnt5, drl and dnt display a penetrance of 16%
(Table 1). Furthermore, males which are hemizygous for Wnt5
and heterozygous for the deficiency display bypassing muscles in
27% of hemisegments (Table 1), a significant increase over the
17% observed in Wnt5 mutant homozygotes. Thus, we conclude
that WNT5 likely signals via both DNT and DRL during muscle
attachment site selection.
LTM ectopic attachments in the Wnt5 and drl mutants
are stable and persist through the larval stages
We next addressed whether the ectopic attachments formed
during embryogenesis are maintained to later stages of develop-
ment. At stage 17 of embryonic development motoneurons
innervating the body wall musculature become electrically active,
enabling the larvae to use its muscles to push out through the
vitelline membrane. The surface area of the larval musculature
increases by approximately a 100-fold in the ensuing stages of
larval development. We examined LTM attachment in Wnt5 and
drl mutants in 3
rd instar larvae just before puparation (5 days AEL)
by staining the muscle fibers and their attachments with an
antibody against the cell adhesion protein FAS2 (Materials and
Methods). The larval LTMs were found to frequently extend
beyond their normal attachment sites. 8% and 16% of hemiseg-
ments contained bypassing LTMs in the Wnt5 and drl mutant
larvae, respectively (compare Fig. 3A with Figs. 3B and 3C;
Table 1). These percentages are roughly half of what is observed
at late embryogenesis suggesting that mutant larvae may have
decreased survival rates due to defects in the nervous system [28]
or other tissues. Clearly, however, a number of the ectopic
attachment sites withstand the mechanical stress of hatching and
the vigorous locomotion associated with larval feeding behavior.
Wnt5 protein and mRNA are present in LTMs and in
tendon cells
To examine whether WNT5 is needed in either the muscle or
the tendon cells for correct attachment we first determined the
developmental patterns of WNT5 expression using anti-WNT5
antisera (Materials and Methods). WNT5 protein expression is first
detected at stage 12 (approximately 10 hours AEL) in the CNS
[28], throughout the epidermis with some accumulation in ventral
Table 1. LTM muscle bypass phenotype in Wnt5, drl and dnt
mutants and restoration of attachment when Wnt5 is present
in tendon cells or muscle.
Genotype
% hemisegments
with bypassing
LTM muscles
n=number of
hemisegments
counted
w
1118 0% 464
Wnt5
400 17% 330
Wnt5
400; UAS-Wnt5/+ 12% 392
Wnt5
400; 24B-GAL4/+ 11% 395
Wnt5
400; UAS-Wnt5/24B-GAL4 0% 391
Wnt5
400; mef2-GAL4/+ 10% 375
Wnt5
400; UAS-Wnt5/mef2-GAL4 0% 334
Wnt5
400; sr-GAL4/+ 20% 365
Wnt5
400; UAS-Wnt5/sr-GAL4 2% 394
Wnt5
400; UAS-Wnt5/
P{GawB}tey
5053A
13% 97
drl
Red2 36% 363
Drl-2
E124 0% 185
drl
Red2,Drl-2
E124 35% 322
Wnt5
400/+;d r l
Red2/+ 0% 200
dnt
42.3 8% 363
drl
Red2/Df(2L)Exel6043 50% 355
drl
Red2/Df(2L)ED1231 50% 354
dnt
42.3/Df(2L)Exel6043 8% 385
Df(2L)ED1231 (drl, dnt) 94% 49
Df(2L)ED1231/+ 0% 100
Df(2L)Exel6043 (drl, dnt) 96% 183
Df(2L)Exel6043/+ 0% 100
Wnt5
400;drl
Red2 36% 382
Wnt5
400; Df(2L)Exel6043/+ 27% 185
Wnt5
400/+; Df(2L)Exel6043/+ 16% 95
Wnt2
L,Wnt4
C1 0% 190
Wnt5
400;Wnt2
L,Wnt4
C1 21% 374
Wnt5
400 3
rd instar larvae 8% 192
drl
Red2 3
rd instar larvae 16% 192
Embryos were stained with anti-Muscle Myosin and hemisegments A2 to A6
were scored for possible bypass by the LTMs. A muscle was scored as bypassing
its attachment site when it extended its tip ventrally beyond muscle fiber 13.
Embryos were sexed by use of anti-Sex-Lethal where appropriate.
doi:10.1371/journal.pone.0032297.t001
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(Fig. 4B). This is the stage when founder cells fuse with myoblasts
and generate the first extending myotubes. WNT5 can be detected
in most muscle fibers, including the LTM muscle fibers 21 to 23,
and in the tendon cells at early stage 16 when the individual
muscle fibers are formed (Fig. 4C). WNT5 expression levels are
significantly reduced at the end of embryonic development (stage
17) (Fig. 4D). A very similar temporal and spatial pattern of
expression was observed for Wnt5 mRNA (Figs. 4E–H),
suggesting that secreted WNT5 protein is present on or close to
the cells in which it is produced. No Wnt5 protein or mRNA was
detected in the Wnt5
400 mutant embryos (data not shown; [28]).
DRL expression in the mesoderm is first detectable around
10 hours AEL and is predominantly concentrated in the
developing LTMs and its expression diminishes significantly by
stage 16 when the fibers have made their attachments to the
tendon cells [39]. DRL is expressed very early in development
from 6 hours AEL onwards in reiterated stripes in the epidermis.
DRL expression is also observed in clusters that partially co-
localize with the SR expression domains at stage 13 [39]. We
observe a similar partial co-localization of the SR and WNT5
protein domains in the early tendon cell precursors (Fig. 5).
As development continues SR expression becomes confined to
the epidermal tendon cells contacted by a muscle fiber. They are
located at the segmental borders for the longitudinal muscles, at
ventrally and dorsally located cells for attachment of the ventral
and dorsal muscles, and in a few lateral groups where the LTMs
attach (Fig. 6; [12]).
Expression of WNT5 in either tendon cells or muscle
fibers is sufficient to establish correct LTM attachment
We used the yeast UAS-GAL4 transactivation system ([43];
Materials and Methods) to determine whether WNT5 is required
by the approaching myofiber or the tendon cell for correct
attachment site selection. We expressed WNT5 specifically in the
developing muscle fibers (mef2-GAL4), the tendon cells (sr-GAL4)
or both (24B-GAL4) in the Wnt5 mutant background. mef2-GAL4
drives expression from early mesoderm formation onwards (stage
10) and in the somatic muscle throughout embryonic development
[44]. 24B-GAL4 also drives expression in mesoderm and somatic
muscle from stage 10 onwards but is also present at the muscle
attachment sites [43]. sr-GAL4 expression follows the endogenous
expression pattern of the stripe promoter and is expressed in tendon
cells and its epidermal precursors [45]. We found that expression
of WNT5 in all muscle or in the tendon cells or in both, rescues
the bypass phenotype in the otherwise Wnt5 mutant background
(Table 1). Wnt5 expression in a single ventral longitudinal muscle
(muscle 12) that is located in the region into which the bypassed
muscle extends, does not inhibit extension of the bypassed muscle
fibers (genotype: Wnt5
400; UAS-Wnt5/P{GawB}tey
5053A,
Table 1).
We confirmed the earlier report [39] that when DRL is
ectopically expressed in muscle only (genotype: dlr
Red2; mef2-
GAL4/UAS-drl) the bypass phenotype is fully rescued, while no
rescue occurs when DRL is expressed only in the attachment sites
(genotype: drl
Red2; sr-GAL4/UAS-drl) (data not shown). These
results indicate that DRL expression is required in the muscle fiber
while WNT5 can either be expressed in certain muscles or in the
tendon cells to restore correct attachment of LTMs.
The bypassed tendon cells continue to express the SR
protein while the novel attachment sites do not in the
majority of the hemisegments
The failure of the LTMs in drl and Wnt5 mutant embryos to
recognize their correct attachment sites in the epidermis might be
a consequence of alterations in the fate or the formation of the
tendon cells. The presence of SR in these cells is both necessary
and sufficient for tendon cell fate [11,13]. Early in development
(stage 12/13) the epidermal clusters of tendon cell precursors
labeled by SR protein in Wnt5 and drl embryos are similar in size
and location to the wild type clusters (data not shown). Later in
development, when muscle fibers and tendon cells are fully
Figure 2. Generation of a dnt mutant by imprecise excision of an adjacent P-element. The P{EP}dnt
EP(2)2158 insert, situated 350 bp
upstream of the dnt ATG initiator codon, was mobilized by providing a source of transposase and imprecise excisions were selected for by loss of the
w
+ marker in the P-element insert and molecularly characterized by sequencing cloned genomic PCR products (Materials and Methods). The locations
of the insertion, the extent of the deletion in the dnt
42.3 allele and gene landmarks, e.g., exons and the location of the WIF encoding segments, are
shown in (A). The dnt
42.3 allele displays dramatically decreased expression of dnt mRNA. Stage 11 wild type (B) and contemporaneously processed
dnt
42.3 mutant (C) embryos hybridized with a dnt antisense probe are shown. Anterior is to the left and dorsal is up in panels (B) and (C).
doi:10.1371/journal.pone.0032297.g002
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Myosin) and the tendon cells (with the anti-SR antibody) in Wnt5
and drl
Red2 mutant embryos and again did not observe any
apparent obvious changes in SR expression patterns. More
specifically, we find that the original bypassed attachment sites
continue to express SR (Figs. 6A–C). However, the novel
epidermal attachment sites that connect the bypassing muscle to
the exoskeleton do not express SR in 65% of the hemisegments
scored (Figs. 6A–C).
We confirmed these results by examining embryos of the
genotypes Wnt5
400; UAS-Tau-MYC/sr-GAL4 and drl
Red2; UAS-
Tau-MYC/sr-GAL4 for Myc and Muscle Myosin expression
(Figs. 6D–F). We conclude that the presence of the SR protein
in the bypassed tendon cell indicates that overshooting by the
muscle fiber is a result of a defect of muscle guidance in drl and
Wnt5 mutant embryos, rather than due to alterations in the fate
or formation of the appropriate tendon cell. bPS integrin, a
protein associated with the myotendinous junction formed at the
end of tendon cell determination, accumulates at the tip of the
overshooting muscle in the Wnt5 and drl mutant embryos
(Fig. 7).
Discussion
The development of the intricate muscle pattern of higher
organisms requires the coordinate expression of numerous cellular
factors regulating the specific fate, differentiation, orientation and
attachment of the individual muscle fibers. The first steps of
muscle formation likely occur autonomously, but guidance of
myofibers towards and attachment to their appropriate tendon
cells are, at least in part, controlled by secreted and transmem-
brane proteins emanating from both the target cell and the
approaching muscle fiber. Here, we have shown that, in Drosophila,
the secreted WNT5 protein and the Ryk transmembrane receptor
Figure 3. Muscle attachment defects persist from the embryonic to larval stages in Wnt5 and drl mutants. Third instar larval body walls
of w
1118 (A), Wnt5
400 (B) and drl
Red2 (C) mutant larvae are stained with anti-FAS2 (mAb 1D4). Wnt5
400 larvae and drl
Red2 larvae frequently bypass their
normal attachment sites and extend ventrally where they form new stable attachments. The original and ectopic tendons cells are indicated by + and
*, respectively. FAS2 protein is evident at both sites. The penetrance of the bypass phenotypes is indicated in Table 1. Anterior is up and ventral is
left.
doi:10.1371/journal.pone.0032297.g003
Figure 4. Wnt5 protein and mRNA expression domains in epidermis, muscle and tendon cells during embryonic development.
WNT5 is predominantly expressed in subsets of neurons in the CNS from stage 12 onwards throughout embryonic development (data not shown;
[28]). However, there is also strong expression from this stage onwards in the epidermis and the musculature. At stage 12, Wnt5 protein (A, B) and
Wnt5 mRNA (E, F) expression is observed in the epidermis, most prominently in two clusters (arrows), and throughout the somatic mesoderm that
will give rise to the body wall musculature. Later in embryonic development at early stage 16 WNT5 protein and Wnt5 mRNA are present in the
attachment sites (arrows in panels C and G) and at low levels in most muscle fibers including the LTMs 21, 22 and 23 (C, G). At the end of
embryonic development at late stage 17, Wnt5 protein (D) and Wnt5 mRNA (H) are almost undetectable in the somatic mesoderm. In all panels
anterior is up and ventral is left.
doi:10.1371/journal.pone.0032297.g004
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subset of embryonic body wall muscle fibers to their tendon cells.
There are three Ryk orthologs in Drosophila, drl, dnt and Drl-2
(reviewed in [22]). We find that 36%, 8%, 0% of hemisegments
display a LTM muscle bypass phenotype when drl, dnt or Drl-2 is
absent, respectively. Homozygosity for relatively small deficiencies
that uncover both drl and dnt results in the bypass phenotype in
virtually all hemisegments (96%). Embryos which completely lack
DRL and are heterozygous for a mutant allele of dnt display
intermediate penetrance of the phenotype (50%). Embryos lacking
DNT and are heterozygous for drl have bypassing muscles in 8%
of their hemisegments. These results suggest that the Ryk family
members, dnt and drl, coordinately regulate the attachment of the
LTM muscle fibers to tendon cells with drl being the dominant
player. The decrease in penetrance in the animals lacking both
copies of drl and one copy of dnt (50%), relative to those completely
lacking both genes (96%), indicates that dnt can at least partially
compensate for the absence of drl. Consistent with this is the
reported ability of the expression of dnt in the LTMs to partially
rescue the drl mutant bypass phenotype [46].
Does WNT5 signal through DNT and DRL? Our genetic
studies indicate that this is likely the case. Female embryos
simultaneously heterozygous for Wnt5 and a deficiency which
uncovers both drl and dnt display the bypass phenotype while those
heterozygous for either Wnt5 or the deficiency alone do not.
Furthermore, male Wnt5 mutant hemizygotes, display increased
penetrance when single copies of drl and dnt are removed. Thus,
we conclude that Wnt5 genetically interacts with drl and dnt, likely
indicating that the WNT5 protein acts as a ligand for these two
Ryk family members during muscle attachment site selection.
DRL is specifically expressed at the muscle tips of fibers 21–23
while they are in the process of extending towards their
attachment sites [39]. The protein is also expressed early in
development from 6 hours AEL (stage 10) onwards in reiterated
stripes in the epidermis and at stage 12 in clusters of epidermal
tendon precursor cells, partially overlapping with the SR
expression domain [39]. Rescue of the drl mutant LTM bypass
phenotype was only achieved when DRL was restored in the
muscle and not the attachment sites. At present, the role of the
early expression of drl in the tendon precursor cells is not clear.
dnt mRNA is also expressed in stripes in the epidermis associated
with invaginating cells [46,47]. This transcript is also present at a
low level in many embryonic tissues including the somatic
musculature. Like DRL, DNT is likely required in the muscle
Figure 5. The WNT5 and SR epidermal expression domains partially overlap. Wild type embryos of stage 13 were double labeled with anti-
SR and anti-WNT5 antibodies and visualized by confocal microscopy. SR protein (red) is present in a number of tendon precursor cells (A). The WNT5
epidermal expression domains (green) in these same embryos are shown in (B). The overlay of these panels is shown in (C). The SR expression
domains partially overlap with the larger WNT5 domains. Anterior is up and ventral is left.
doi:10.1371/journal.pone.0032297.g005
Figure 6. The new attachment sites of the bypassed muscle fibers in Wnt5 and drl mutants frequently do not express SR, while the
bypassed attachment sites do. Double labeled stage 16 embryos are shown of w
1118 (A), Wnt5
400 (B) and drl
Red2 (C) with anti-Muscle Myosin in
green and anti-SR in red (Material and Methods). Asterisks mark the novel attachment sites of the overshooting LTM muscles; white arrowheads mark
the locations of the original attachment sites. In Wnt5 mutants the novel target sites do not express SR in 65% of the segments containing
overshooting muscles, while the bypassed attachment sites usually express SR. The SR positive, original tendon cell is also present in drl
Red2 mutants,
but is partly masked by the overshooting muscle fiber in panel (C), but clearly visible in panel (F)). These results were confirmed in embryos that
express Tau-MYC under the control of a stripe promoter in both Wnt5 and drl mutants (data not shown). The following genotypes are shown, the
control UAS-Tau-MYC; sr-GAL4 embryos (D), Wnt5
400; UAS-Tau-MYC/sr-GAL4 (E) and drl
Red2; UAS-Tau-MYC/sr-Gal4 (F). Anti-Muscle Myosin is shown in
green and anti-MYC in red. No MYC protein is observed in the ectopic attachment sites. The photographs in Panels (A–C) were taken on a compound
microscope and those in Panels (D–F) on a confocal microscope. Anterior is up and ventral is left.
doi:10.1371/journal.pone.0032297.g006
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phenotype. DRL-2 is most predominantly expressed in the central
nervous system (data not shown), suggesting that it was unlikely to
have a role in LTM guidance, as was shown in this study. While
almost all hemisegments display overshooting LTMs in the
absence of DRL and DNT, only one or two of the three LTM
fibers, usually muscles 21 and/or 23, exhibit this phenotype. This
result indicates that other non Ryk-dependent mechanisms are
required to guide these three muscles to their attachment sites.
Alternatively, these two muscles may experience fewer physical
barriers blocking their ventral extension beyond muscle 12. In
addition, the overshooting of the appropriate tendon cells by these
muscles is only observed at the ventral and not the dorsal
attachment sites, indicating that guidance mechanisms differ for
the two ends of the muscle.
WNT5 has an important role in guidance of embryonic central
nervous system commissural axons [28,29] and the salivary glands
[48] and acts as a ligand for DRL in these tissues. When we
investigated LTM trajectories in Wnt5 mutant embryos we found
that one or more LTMs overshoot their normal tendon cells in
only 17% of the hemisegments compared with 36% in the drl
mutant. This result suggests that there are likely other DRL
ligands in addition to WNT5. Possible other candidates include
the other six wnt genes present in Drosophila, wg, Wnt2, Wnt4, Wnt6,
Wnt8 and Wnt10 (reviewed at ‘‘The Wnt Home page’’ (www.
stanford.edu/group/nusselab/cgi-bin/wnt)). Segmentation defects
during early embryogenesis in wg mutants and the lack of available
mutants for Wnt6 and Wnt10 precludes further analyses of muscle
pattern formation in the absence of these genes. Furthermore,
Wnt8 is not detectably expressed in the somatic mesoderm [49,50].
Since both Wnt2 and Wnt4 had been previously implicated in
diverse stages of muscle formation and function [42,51] we
analyzed LTM trajectories in a Wnt2/Wnt4 double mutant. We
did not observe any bypassing LTMs in the double mutant
embryos, nor in the singly homozygous mutants, indicating that
these two Wnt genes are not likely involved in regulating LTM
attachment. WNT10 is the most probable alternative ligand for
DRL and DNT in muscle since its mRNA is expressed in the
developing somatic mesoderm [52], however evaluation of its
potential roles awaits the generation of a mutant allele.
In which cells is WNT5 expressed and required? We found that
Wnt5 mRNA and protein are expressed at low levels in all somatic
muscles while they are extending, in mature attachment sites and
also during early development in a subset of the tendon cell
precursors and in the epidermis. Furthermore, rescue of the bypass
phenotype is seen when a Wnt5 transgene is expressed in either of
these two tissues. Since WNT5 is a secreted factor and rescue of
the Wnt5 phenotype is observed with restoration in either the
muscle or the tendon cells, it is difficult to conclude unambiguously
in which tissue it is needed. Restoring expression of WNT5 in
muscle fiber 12 only does not rescue the bypass phenotype. This
result suggests that it is not simply sufficient to have a high source
of WNT5 in the muscle close to the original attachment sites for
appropriate inhibition of LTM extension. It is more likely, that
WNT5, which is widely expressed in the epidermis and
musculature, is modified in some way to become locally activated
as a specific LTM repulsive guidance cue. Support for this
hypothesis comes from previous observations that Wnt5 is
proteolytically-processed [53]. Furthermore, WNT5 expressed by
anterior commissural midline glial cells, but not in all neurons,
blocks anterior commissure formation [28] due to the repulsion of
DRL
+ axons, indicating that elevated local expression of WNT5
can have different outcomes depending on the cell types which
express it. Finally, although WNT5 is observed to be widely
expressed in the larval/adult brain, it acts specifically to guide
mushroom body a-lobe axons [54] indicating that an apparently
ubiquitously-expressed ligand can act as a directional cue.
Alternatively, WNT5 may be sequestered from some regions of
the extending muscle fiber by so-called ‘‘extrinsic receptors’’ [55]
which results in a directional cue received by the leading edge of
the muscle.
There is mounting evidence that the final differentiation of the
Drosophila tendon cell, in particular the secretion of an elaborate
extracellular matrix, is tightly coupled to the arrival of the muscle
fiber (reviewed in [2]). The resulting myotendinous junction is
essential for force transmission and counteraction of muscle
contraction by tendon cells. Similar junctions exist in vertebrates
where tendons attach the muscles to the bone. In Drosophila,i t
consists of hemi-adherens junction formed by the association of
integrin receptor heterodimers on the muscle tip and the tendon
cell with the intercalating ECM proteins [2] such as Laminin and
TSP secreted from the tendon cells and Tiggrin from the muscle
cell. The myotendinous junction is not functional when integrin,
TSP or laminin are absent resulting in dissociation of fibers from
their attachment sites which leads to lethality. The signals allowing
recognition of the appropriate tendon cell, arrest of muscle fiber
extension and the formation of the myotendinous junction remain
unclear. However, genetic phenotypic analyses indicate that
changes in local integrin receptor accumulation on muscle tips
and differential responses to TSP presented on the tendons might
slow down and stop muscle migration prior to the initiation of
myotendinous junction formation (reviewed in [2]). A functional
myotendinous junction is formed at the novel attachment site of
Wnt5 and drl mutants as evidenced by our observation that bPS
Figure 7. The new attachment sites of the bypassed muscle fibers in Wnt5 and drl mutants express bPS integrin. Wild type (A), Wnt5
400
(B) and drl
red2 (C) embryos were labelled with anti-bPS Integrin. Muscles 21–23 do exhibit an accumulation of bPS Integrin protein at the tip of the
overshooting fibers (white asterix).
doi:10.1371/journal.pone.0032297.g007
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expression at the original attachment site indicating that the
interaction of the muscle tip with the bypassed site, if it occurs at
all, is not of sufficient duration to initiate attachment site
maturation.
The observation that the initial outgrowth and guidance of the
LTMs are normal in Wnt5 and drl mutants suggests that these
proteins act during the recognition of the target cell and not earlier
during muscle extension. Wnt/Ryk signaling may be required for
induction of a localized ‘‘stop’’ signal for the LTM at its normal
attachment site. In this scenario DRL and DNT present on muscle
fibers 21–23 would bind activated WNT5 secreted from their
normal attachment sites. This interaction might then result in the
transcription of genes encoding extracellular matrix proteins in the
muscle fiber which are required to increase adhesiveness between
the muscle and tendon cell, slowing down the fibers extension.
When either WNT5 or DRL/DNT is absent this signal is not
appropriately received by the approaching fiber and it overshoots
its target and attaches relatively randomly to a more distant
epidermal cell.
In the Drosophila embryonic CNS, DRL acts as a repulsive
guidance receptor on growth cones of anterior commissural axons
to steer them away from the posterior commissural axons which
express WNT5. It seemed thus possible that DRL/DNT also acts
in the muscle as a repulsive receptor upon binding of WNT5.
However, we did not observe any clear muscle guidance defects
when WNT5 was ectopically expressed on either specific muscle
fibers or in the tendon cells (data not shown). As mentioned above,
it is possible that WNT5 has to be locally modified and activated
or differentially sequestered to function as a guidance cue in this
tissue.
We found that that the novel attachment site for the
overshooting muscle in embryos and larvae is an epidermal cell
and not another muscle. The normal LTM attachment site that is
not recognized by the bypassing muscle is present in Wnt5 and drl
mutants as visualized by its ability to express SR, a transcription
factor that is both necessary and sufficient to drive tendon cell fate.
Therefore, this tendon cell follows important early stages of
normal tendon cell differentiation, but does not bind the fiber.
In contrast, only 35% of the ectopic tendon cells express SR
suggesting that SR expression is not obligatorily required for
formation of a stable myotendinous junction. At present, we do not
know whether the novel attachment site expressed SR earlier in
development or whether, despite its stability against contraction-
induced damage, the ectopic myotendinous junction is different in
some manner from the normal junction as to not allow
maintenance of SR expression. We find that the FAS2 protein
that is normally expressed at the muscle tip and the tendon cell to
which it attaches, is present at both the original and the novel
attachment sites in drl and Wnt5 mutant larvae. This result
indicates that the muscle ‘‘filopodia’’ likely transiently interact with
its normal tendon cell target but does not cease extension. This
further supports the notion that Wnt/Ryk signaling may increase
the stability of muscle/tendon cell interactions.
It is too early to evaluate whether the molecular mechanisms of
muscle attachment site selection are conserved between verte-
brates and invertebrates because of the paucity of knowledge
about the molecules required for tendon differentiation and its
connections to muscle and skeletal tissues in vertebrates.
Components of Integrin-mediated adhesion complexes, e. g., talin
1 and talin 2 and several laminin integrin receptors were, however,
recently shown to be essential for the formation of the vertebrate
myotendinous junction [56], as has been observed for their
orthologs in Drosophila (reviewed in [2]). In the coming years, as
more becomes known about the mechanisms that mediate the
connections between muscles and tendons, it will be apparent
whether other aspects of muscle guidance and target site selection
are also conserved.
Materials and Methods
Drosophila stocks
All Drosophila stocks were grown on standard cornmeal medium
at 22uC. The following mutant alleles, GAL4 drivers and UAS-
reporter lines were obtained from their originating laboratories or
the Bloomington Drosophila Stock Center and used in this study:
w
1118, Wnt5
400 [28], drl
Red2 [23], Drl-2
E124 [42], dnt
42.3 (this study),
sr-GAL4 [45], UAS-Wnt5 [28], 24B-GAL4 [43], mef2-GAL4
([44], UAS-Tau-MYC [57], P{GawB}tey
5053A [58], the wnt
2L,
wnt4
C1 double mutant and the Df(2L)ED1231 and Df(2L)Exel6043
deficiencies [59].
Generation of Dnt mutants
A mutant allele of dnt, dnt
42.3, was generated by imprecise
excision of the P-element insertion P{EP}dnt
EP(2)2158 obtained
from the Szeged Stock Center following a standard P-element
mobilization strategy [60]. Sequences of the primers used to
identify the deletion are available upon request. The dnt
42.3 mutant
line is viable and has a deletion of 2322 base pairs from positions
19360852 to 19363174 of chromosome 2L (accession number
GB:AE014134). This deletion uncovers most of the first exon of
the Dnt transcript including the ATG initiator codon, the first 15
amino acids of the Wnt-binding WIF domain and the splice donor
site. RNA in situ analysis of the dnt mutant line reveals that the
mutant embryos do not detectably express the dnt transcript
(compare Figs. 2B and 2C).
RNA in situ hybridization
Embryo collections for RNA in situ hybridization were carried
out at 22uC. RNA in situ hybridization and staging of embryos
were performed as described [28]. dnt RNA and Wnt5 RNA
antisense probes were hybridized to paraformaldehyde fixed
embryos. The dnt probe included positions 386–1225 of the dnt
RA transcript (accession number NM_057993). The Wnt5
antisense probe was generated by SP6 polymerase transcription
of EcoRV-linearized pOT2-LD22614, which bears the full Wnt5
open reading frame.
Immunohistochemistry
All embryo collections for immunohistochemistry were carried
out at 22uC. Antibody labelings were performed as described
[38]. The following primary antibodies were used on formalde-
hyde-fixed embryos or third instar larval body walls: anti-Muscle-
Myosin mAb (Invitrogen), anti-FAS2 (1D4, Developmental
Studies Hybridoma Bank (DSHB)), anti-bPS Integrin
(CF.6G11; DSHB), guinea pig anti-SR (gift from T. Volk;
[11]), rabbit-anti-GFP (Upstate), anti-Sex-Lethal ([61]; DSHB),
rabbit anti-MYC (Upstate) and affinity-purified rabbit anti-
WNT5 [28]. Secondary antibodies used were: HRP-conjugated
goat anti-mouse or anti-rabbit (Jackson Laboratories) and
AlexaFluor-488-conjugated and AlexaFluor-568-conjugated goat
anti-mouse and goat anti-rabbit, respectively (Invitrogen). HRP
staining was visualized by a standard DAB reaction. After
antibody staining, embryos were stored in 70% glycerol in PBS
and then dissected and imaged with an Axioplan2 microscope
fitted with an Axiocam digital camera (Zeiss) or using an LCS
(Leica) confocal microscope.
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